Download Free Drug Taking Behavior Among School Aged Youth Book in PDF and EPUB Free Download. You can read online Drug Taking Behavior Among School Aged Youth and write the review.

Use this valuable knowledge about drug-taking behavior to plan strategies to prevent or reduce drug-taking among youth. The findings from this unique study have important implications for researchers, educators, practitioners, and local and state policymakers and planners for the development of initiatives for addressing smoking, drinking, and drug use among early adolescents and teenagers. The purpose of this informative volume is to further understand drug-taking behavior among adolescents by providing information on the prevalence, correlates, and consequences of drug-taking behavior among a large sample of adolescents. Although the focus is on Alaska, the findings generalize to comparably aged youth in general; moreover, comparisons with findings from national studies and other states provide interesting results.
Adolescence is a time when youth make decisions, both good and bad, that have consequences for the rest of their lives. Some of these decisions put them at risk of lifelong health problems, injury, or death. The Institute of Medicine held three public workshops between 2008 and 2009 to provide a venue for researchers, health care providers, and community leaders to discuss strategies to improve adolescent health.
Bullying has long been tolerated as a rite of passage among children and adolescents. There is an implication that individuals who are bullied must have "asked for" this type of treatment, or deserved it. Sometimes, even the child who is bullied begins to internalize this idea. For many years, there has been a general acceptance and collective shrug when it comes to a child or adolescent with greater social capital or power pushing around a child perceived as subordinate. But bullying is not developmentally appropriate; it should not be considered a normal part of the typical social grouping that occurs throughout a child's life. Although bullying behavior endures through generations, the milieu is changing. Historically, bulling has occurred at school, the physical setting in which most of childhood is centered and the primary source for peer group formation. In recent years, however, the physical setting is not the only place bullying is occurring. Technology allows for an entirely new type of digital electronic aggression, cyberbullying, which takes place through chat rooms, instant messaging, social media, and other forms of digital electronic communication. Composition of peer groups, shifting demographics, changing societal norms, and modern technology are contextual factors that must be considered to understand and effectively react to bullying in the United States. Youth are embedded in multiple contexts and each of these contexts interacts with individual characteristics of youth in ways that either exacerbate or attenuate the association between these individual characteristics and bullying perpetration or victimization. Recognizing that bullying behavior is a major public health problem that demands the concerted and coordinated time and attention of parents, educators and school administrators, health care providers, policy makers, families, and others concerned with the care of children, this report evaluates the state of the science on biological and psychosocial consequences of peer victimization and the risk and protective factors that either increase or decrease peer victimization behavior and consequences.
Alcohol use by young people is extremely dangerous - both to themselves and society at large. Underage alcohol use is associated with traffic fatalities, violence, unsafe sex, suicide, educational failure, and other problem behaviors that diminish the prospects of future success, as well as health risks â€" and the earlier teens start drinking, the greater the danger. Despite these serious concerns, the media continues to make drinking look attractive to youth, and it remains possible and even easy for teenagers to get access to alcohol. Why is this dangerous behavior so pervasive? What can be done to prevent it? What will work and who is responsible for making sure it happens? Reducing Underage Drinking addresses these questions and proposes a new way to combat underage alcohol use. It explores the ways in which may different individuals and groups contribute to the problem and how they can be enlisted to prevent it. Reducing Underage Drinking will serve as both a game plan and a call to arms for anyone with an investment in youth health and safety.
Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.
*HA13, Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs, Robert H. Coombs(UCLA School of Medicine), Douglas M. Ziedonis(Yale University School of Medicine), 37755-6, 608 pp., 7 x 9 1/4, 0-133-77557-7, casebound, 1995, $20.00nk, January*/This hard-hitting handbook addressing substance abuse is comprised of chapters written by a variety of leading experts in the drug prevention/treatment field. This volume specifies proven and effective techniques, critiques ineffective and counterproductive approaches, and proposes options for retaliation against the on-going war.
CSA Sociological Abstracts abstracts and indexes the international literature in sociology and related disciplines in the social and behavioral sciences. The database provides abstracts of journal articles and citations to book reviews drawn from over 1,800+ serials publications, and also provides abstracts of books, book chapters, dissertations, and conference papers.
Written for all pediatric clinicians and students, Problems in Pediatric Drug Therapy is an authoritative, well-referenced, and accessible source of essential information on the use and effects of drugs in infants and children. Twenty widely published clinicians, educators, and researchers from pharmacy, medicine, and nursing have authored 14 chapters, each dealing with a major, potentially problematic area of pediatric drug therapy. Building on the well-received previous editions -- the third edition was named an American Journal of Nursing Book of the Year in the category of pediatric nursing -- the fourth edition focuses on the key concerns in pediatric drug therapy today: drug administration, pharmacokinetics, drugs as teratogens and fetotoxins, excretion of drugs into breast milk, pediatric poisoning, adverse reactions, drug interactions, drug abuse, IV drugs, and immunizations. Two new chapters cover the increasingly important areas of pediatric antineoplastic therapy and pharmacogenetics. The concluding two hallmark chapters on dosing in neonates and in infants, children, and adolescents, respectively, have been expanded and updated to reflect current trends in drug use.